Injection of recombinant retrovirus significantly decreased xenogeneic graft tumor volume

The upper row in the pictures show xenogeneic graft tumor specimens treated with saline as control. The lower row show xenogeneic graft tumor specimens treated with recombinant C3 retrovirus. The lower quartile, median and the upper quartile is 57.6 mg, 79.8 mg, 124.7 mg, respectively in control. The lower quartile, median and the upper quartile is 18.1 mg, 33.5 mg and 42.7 mg respectively in treated (P = 0.003, n = 8).<p><b>Copyright information:</b></p><p>Taken from "Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells and "</p><p>http://www.biomedcentral.com/1471-2407/8/29</p><p>BMC Cancer 2008;8():29-29.</p><p>Published online 29 Jan 2008</p><p>PMCID:PMC2270850.</p><p>